All Stories

  1. A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

    Article • Clinical Ophthalmology, January 2019, Dove Medical Press

    Melissa Toyos

  2. A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

    Article • Clinical Ophthalmology, December 2018, Dove Medical Press

    Melissa Toyos

  3. A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

    Article • Clinical Ophthalmology, October 2018, Dove Medical Press

    Melissa Toyos

  4. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]

    Article • Clinical Ophthalmology, May 2018, Dove Medical Press

    Melissa Toyos

  5. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial

    Article • Clinical Ophthalmology, January 2018, Dove Medical Press

    Melissa Toyos

  6. Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies

    Article • Ocular Immunology and Inflammation, December 2017, Taylor & Francis

    Dr charles stephen foster, Melissa Toyos